Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A comprehensive safety and tolerability study evaluated approximately 900 participants across six trials with the following protocols: Subcutaneous/Intravenous Protocols: Single doses ranging from 25 to 400 mcg/kg body weight were tested
While these anecdotes can be pretty convincing for some people, theyre not supported by any scientific evidence
No basis for a Therapeutic Use Exemption
AmbioPharm is a powerhouse of US peptide manufacturing, headquartered in South Carolina, and operates as a CDMO focused on generic peptide APIs and contract manufacturing for clinical programs
Check whether the peptide is legal in your state
US$ 26.91
US$ 24.58
US$ 26.43
US$ 21.42
